{"id":161184,"title":"Notice to Stakeholders - Updates to drug establishment licence applications and good manufacturing practice evidence requirements for active pharmaceutical ingredients - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T05:45:30.130000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/notice-stakeholders-updates-drug-establishment-licence-applications-good-manufacturing-practice-evidence-requirements-active-pharmaceutical.html?wbdisable=true","snippet":"Notice to Stakeholders - Updates to drug establishment licence applications and good manufacturing practice evidence requirements for active pharmaceutical ingredients - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du…","rawSnapshotUrl":"/api/snapshots/raw/161184","browseUrl":"https://replay.healtharchive.ca/job-1/20250419054530/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/notice-stakeholders-updates-drug-establishment-licence-applications-good-manufacturing-practice-evidence-requirements-active-pharmaceutical.html?wbdisable=true#ha_snapshot=161184","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}